The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125073062 12507306 2 F 2016 20160704 20160629 20160718 EXP GB-AUROBINDO-AUR-APL-2016-08104 AUROBINDO 42.00 YR F Y 0.00000 20160718 OT GB GB

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125073062 12507306 1 PS Ondansetron ONDANSETRON 1 Unknown UNK U U 78539
125073062 12507306 2 SS Ondansetron ONDANSETRON 1 UNK U U 78539
125073062 12507306 3 SS APREPITANT. APREPITANT 1 Oral 80 MG, ONCE A DAY (TAKEN ON DAY 2 AND 3 AFTER CHEMOTHERAPY) U U 0 80 MG QD
125073062 12507306 4 SS APREPITANT. APREPITANT 1 Oral 80 MG, ONCE A DAY (TAKEN ON DAY 2 AND 3 AFTER CHEMOTHERAPY) U U 0 80 MG QD
125073062 12507306 5 SS FLUOROURACIL. FLUOROURACIL 1 Unknown UNK, EVERY 3 WEEKS (CYCLICAL) U U 0
125073062 12507306 6 SS FLUOROURACIL. FLUOROURACIL 1 UNK, EVERY 3 WEEKS (CYCLICAL) U U 0
125073062 12507306 7 SS DEXAMETHASONE. DEXAMETHASONE 1 Oral 2 MG, ONCE DAILY, 3 DAYS U U 0 2 MG TABLET QD
125073062 12507306 8 SS DEXAMETHASONE. DEXAMETHASONE 1 Oral 2 MG, ONCE DAILY, 3 DAYS U U 0 2 MG TABLET QD
125073062 12507306 9 SS DOCETAXEL. DOCETAXEL 1 Unknown 3 CYCLES U U 0
125073062 12507306 10 SS DOCETAXEL. DOCETAXEL 1 3 CYCLES U U 0
125073062 12507306 11 SS LEVOMEPROMAZINE LEVOMEPROMAZINE 1 Unknown UNK U U 0
125073062 12507306 12 SS LEVOMEPROMAZINE LEVOMEPROMAZINE 1 UNK U U 0
125073062 12507306 13 SS METOCLOPRAMIDE. METOCLOPRAMIDE 1 Unknown UNK U U 0
125073062 12507306 14 SS METOCLOPRAMIDE. METOCLOPRAMIDE 1 UNK U U 0
125073062 12507306 15 SS NEULASTA PEGFILGRASTIM 1 Subcutaneous 6 MG, 24 HOURS AFTER CHEMOTHERAPY U U 0 6 MG
125073062 12507306 16 SS NEULASTA PEGFILGRASTIM 1 Subcutaneous 6 MG, 24 HOURS AFTER CHEMOTHERAPY U U 0 6 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125073062 12507306 1 Product used for unknown indication
125073062 12507306 3 Product used for unknown indication
125073062 12507306 5 Product used for unknown indication
125073062 12507306 7 Product used for unknown indication
125073062 12507306 9 Product used for unknown indication
125073062 12507306 11 Product used for unknown indication
125073062 12507306 13 Product used for unknown indication
125073062 12507306 15 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
125073062 12507306 HO
125073062 12507306 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
125073062 12507306 Arthralgia
125073062 12507306 Constipation
125073062 12507306 Decreased appetite
125073062 12507306 Deep vein thrombosis
125073062 12507306 Fatigue
125073062 12507306 Oral pain
125073062 12507306 Pain
125073062 12507306 Pain in extremity
125073062 12507306 Peripheral swelling
125073062 12507306 Vascular pain

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found